Increased erythropoietin level and reticulocyte count during arsenic trioxide therapy

Leukemia. 2005 Apr;19(4):674-6. doi: 10.1038/sj.leu.2403635.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects
  • Arsenic Trioxide
  • Arsenicals / administration & dosage*
  • Arsenicals / adverse effects
  • Erythropoietin / blood*
  • Female
  • Humans
  • Leukemia, Promyelocytic, Acute / blood
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Male
  • Middle Aged
  • Oxides / administration & dosage*
  • Oxides / adverse effects
  • Reticulocyte Count*

Substances

  • Antineoplastic Agents
  • Arsenicals
  • Oxides
  • Erythropoietin
  • Arsenic Trioxide